Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
- Products
-
- Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP
- Company
- Cipla USA, Inc.
- Where it was sold
-
USA nationwide.
Nationwide
- Units affected
- 59244/3ml FFS packs
- About this recall
- Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53